Literature DB >> 10823203

Anomer-selective inhibition of glycosidases using aminocyclopentanols.

E Leroy1, J L Reymond.   

Abstract

[reaction: see text] (1S,2S,3S,4R,5R)-4-amino-5-(hydroxymethyl)cyclopentane-1,2,3-triol 1 is prepared stereoselectively from D-lyxose and displays anomer-selective inhibition for beta-galactosidase (Ki = 3.0 x 10(-6) M) and beta-glucosidase (Ki = 1.5 x 10(-7) M), over alpha-galactosidase (Ki = 2.3 x 10(-5) M) and alpha-glucosidase (IC50 = 1.0 x 10(-4) M). There is no observable cross-reactivity with alpha-mannosidase, beta-mannosidase, or alpha-L-fucosidase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10823203     DOI: 10.1021/ol990754m

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  C(1)-/C(2)-aromatic-imino-glyco-conjugates: experimental and computational studies of binding, inhibition and docking aspects towards glycosidases isolated from soybean and jack bean.

Authors:  Amit Kumar; Nitin K Singhal; Balaji Ramanujam; Atanu Mitra; Nagender R Rameshwaram; Siva K Nadimpalli; Chebrolu P Rao
Journal:  Glycoconj J       Date:  2008-10-25       Impact factor: 2.916

2.  New α-galactosidase-inhibiting aminohydroxycyclopentanes.

Authors:  Patrick Weber; Roland Fischer; Seyed A Nasseri; Arnold E Stütz; Martin Thonhofer; Stephen G Withers; Andreas Wolfsgruber; Tanja M Wrodnigg
Journal:  RSC Adv       Date:  2021-04-29       Impact factor: 4.036

3.  Structure-Activity Studies of N-Butyl-1-deoxynojirimycin (NB-DNJ) Analogues: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2.

Authors:  Xingxian Gu; Vijayalaxmi Gupta; Yan Yang; Jin-Yi Zhu; Erick J Carlson; Carolyn Kingsley; Joseph S Tash; Ernst Schönbrunn; Jon Hawkinson; Gunda I Georg
Journal:  ChemMedChem       Date:  2017-11-24       Impact factor: 3.466

4.  Mechanistic Insights into the Chaperoning of Human Lysosomal-Galactosidase Activity: Highly Functionalized Aminocyclopentanes and C-5a-Substituted Derivatives of 4-epi-Isofagomine.

Authors:  Patrick Weber; Martin Thonhofer; Summer Averill; Gideon J Davies; Andres Gonzalez Santana; Philipp Müller; Seyed A Nasseri; Wendy A Offen; Bettina M Pabst; Eduard Paschke; Michael Schalli; Ana Torvisco; Marion Tschernutter; Christina Tysoe; Werner Windischhofer; Stephen G Withers; Andreas Wolfsgruber; Tanja M Wrodnigg; Arnold E Stütz
Journal:  Molecules       Date:  2020-09-03       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.